tirzepatide pediatric Big update in diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA-approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ Tirzepatide Lowers A1c, BMI in

Unlike oral semaglutide (Rybelsus), which co-formulates the semaglutide peptide with the absorption enhancer SNAC and requires patients to take the medication on an empty stomach with no more than 4 ounces of water and then wait at least 30 minutes before eating, orforglipron achieves oral bioavailability of approximately 79% without any such restrictions

In 22 24-month-old mice given 10 mg/kg once daily for 8 weeks, sedentary animals gained roughly 40% grip strength over controls, and animals that also exercised gained about 60%

Inject at least 2 inches from the belly button

Persistent or Severe Symptoms: Ongoing nausea, vomiting, or severe headaches beyond the initial adjustment phase